Characterization of patient perception of odor severity in hidradenitis suppurativa using TARGET-DERM HS.
Characterization of patient perception of odor severity in hidradenitis suppurativa using TARGET-DERM HS
Publications
Read more →
Healthcare Disparities in Hidradenitis Suppurativa in the US: TARGET-DERM HS.
Healthcare Disparities in Hidradenitis Suppurativa in the US: TARGET-DERM HS
Machine learning–based identification of moderate-to-severe atopic dermatitis in US patients using the TARGET-DERM AD registry.
Machine learning–based identification of moderate-to-severe atopic dermatitis in US patients using the TARGET-DERM AD registry
A comparison of stable vs progressive hidradenitis suppurativa: insights from TARGET-DERM HS.
A comparison of stable vs progressive hidradenitis suppurativa: insights from TARGET-DERM HS
The impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM.
The impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
160
Total Publications
46
Abstract / Manuscript
17
Oral Presentation
97
Poster Presentation
2026 · Poster Presentation · Poster Presentation · Dermatology
Characterization of patient perception of odor severity in hidradenitis suppurativa using TARGET-DERM HS.
Read more →2026 · Poster Presentation · Poster Presentation · Dermatology
Healthcare Disparities in Hidradenitis Suppurativa in the US: TARGET-DERM HS.
Read more →2026 · Poster Presentation · Poster Presentation · Dermatology
Machine learning–based identification of moderate-to-severe atopic dermatitis in US patients using the TARGET-DERM AD registry.
Read more →2026 · Poster Presentation · Poster Presentation · Dermatology
A comparison of stable vs progressive hidradenitis suppurativa: insights from TARGET-DERM HS.
Read more →2026 · Poster Presentation · Poster Presentation · Dermatology
The impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM.
Read more →2026 · Poster Presentation · Poster Presentation · Dermatology
Real world characteristics and burden of patients initiating advanced systemic therapy in the TARGET-DERM atopic dermatitis registry.
Read more →2026 · Poster Presentation · Poster Presentation · Gastroenterology
Characterization and Impact of Risankizumab on patients with Fistulizing Crohn’s Disease in the Real World: Findings from TARGET-GASTRO.
Read more →2026 · Poster Presentation · Poster Presentation · Gastroenterology
Characterization and Impact of Upadacitinib on patients with Fistulizing Crohn’s Disease in the Real World: Findings from TARGET-GASTRO.
Read more →2026 · Poster Presentation · Poster Presentation · Gastroenterology
Impact Of Early Endoscopic Remission After Advanced Therapy On Long-Term Complications In Crohn's Disease: Findings From TARGET-IBD.
Read more →2026 · Poster Presentation · Poster Presentation · Gastroenterology
Impact Of Early Endoscopic Remission After Advanced Therapy On Long-Term Complications In Ulcerative Colitis: Findings From TARGET-IBD.
Read more →2025 · Poster Presentation · Poster Presentation · Hepatology
Real world treatment patterns and outcomes for hepatocellular carcinoma (HCC) patients receiving transarterial chemoembolization (TACE) or transarterial radioembolization (TARE) in the TARGET-HCC registry.
Read more →2025 · Poster Presentation · Approval / Commercialization · Hepatology
Real-World Treatment Patterns Among US Adults with Enresectable Hepatocellular Carcinoma (HCC) Eligible For Locoregional Therapy (LRT).
Read more →2025 · Poster Presentation · Poster Presentation · Dermatology
Correlation between achieving SALT 20 score and clinician- and patient-reported outcomes among patients diagnosed with alopecia areata in the US: An assessment from the TARGET-DERM AA registry.
Read more →2025 · Poster Presentation · Poster Presentation · Dermatology
Race and ethnicity sub-groups of alopecia areata patients have differing clinical characteristics: TARGET-DERM AA.
Read more →2025 · Poster Presentation · Poster Presentation · Dermatology
Generic vs. disease-specific patient reported outcome (PRO) instruments for assessing HRQoL burden among patients diagnosed with alopecia areata: Evidence from TARGET-DERM AA.
Read more →2025 · Poster Presentation · Poster Presentation · Methods/Pharmacoepi
Power Vs. Precision When Estimating Risk Differences Using Observational Data? A Case Study From TARGET-IBD.
Read more →2025 · Abstract / Manuscript · Abstract / Manuscript
The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASH.
Read more →2025 · Abstract / Manuscript · Abstract / Manuscript
Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease.
Read more →2025 · Abstract / Manuscript · Abstract / Manuscript
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy.
Read more →2025 · Poster Presentation · Poster Presentation · Hepatology
Changes in The Fibrosis-4 (FIB-4) Score Accurately Reflects The Disease Trajectory of Metabolic Dysfunction Associated Steatotic Liver Disease.
Read more →2025 · Poster Presentation · Poster Presentation · Hepatology
Clinical Characteristics of Patients With Presumed MASLD Who Meet Met-ALD Criteria in the TARGET-NASH Cohort.
Read more →2025 · Poster Presentation · Poster Presentation · Hepatology
Relationship between non-invasive tests, clinical outcomes and liver biopsy among people with MASH under real-world conditions.
Read more →2025 · Poster Presentation · Poster Presentation · Hepatology
Type 2 Diabetes and Obesity are The Main Metabolic Risk Factors for The Development of Cirrhosis in People with Metabolic Dysfunction Associated Steatohepatitis.
Read more →2025 · Abstract / Manuscript · Abstract / Manuscript
Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry.
Read more →2025 · Poster Presentation · Poster Presentation · Methods/Pharmacoepi
Missing the Mark: Treat-to-Target Gaps in Real-World Ulcerative Colitis Care.
Read more →2025 · Abstract / Manuscript · Abstract / Manuscript
Leveraging public health infrastructures to support sexual health for women living in the Southern United States.
Read more →2025 · Poster Presentation · Poster Presentation · Methods/Pharmacoepi
Treat-to-Target Gaps in Crohn’s Disease: Insights from Real-World Practice.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
Type 2 diabetes increases the risk of progression to metabolic dysfunction-associated steatohepatitis-related cirrhosis in a real world setting.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
Stability of the NASH-CHECK patient-reported outcome measure over time in patients with metabolic dysfunction-associated steatotic liver disease and stable clinical status.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
A prospective assessment of the impact of decompensation of cirrhosis on patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
Time to Disease Progression and All-Cause Mortality in Adult MASH Patients in Real-World US Cohort.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
Characteristics of adult MASH patients and factors associated with MASH-relevant clinical endpoints in a real-world US cohort.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
Understanding Metabolic Dysfunction-Associated Steatohepatitis: Differences in Clinical and Demographic Characteristics Across Racial and Ethnic Groups.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
Use of sodium-glucose transport protein 2 inhibitors and dipeptidyl peptidase 4 inhibitors in patients with MASLD in a real-world setting is associated with lower all-cause mortality.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
Real-World Use of Glucagon-Like Peptide 1 Receptor Agonists in Patients with MASLD: A Cross-Sectional Analysis from TARGET-NASH.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
A prospective assessment of disease progression impact on patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
Non-invasive tests as a prediction tool to assess MASH resolution score.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
A longitudinal assessment of cardiovascular risk for NASH/MASH patients enrolled in TARGET-NASH.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
Complication-Free Survival in a Real-World Cohort of PBC Patients: Deep Versus Adequate ALP Response to UDCA.
Read more →2024 · Poster Presentation · Poster Presentation · Dermatology
Demographics and disease characteristics of patients with alopecia areata with comorbid atopic dermatitis, vitiligo or anxiety/depression: TARGET-DERM AA.
Read more →2024 · Poster Presentation · Poster Presentation · Dermatology
Why Do Optimal Targets for Itch and Skin Clearance Matter in Atopic Dermatitis Treatment? Insights from the TARGET-DERM AD Registry.
Read more →2024 · Poster Presentation · Poster Presentation · Dermatology
Real-world study of hidradenitis suppurativa: skin lesions and pain are associated with Hurley Stage in TARGET-DERM HS.
Read more →2024 · Poster Presentation · Poster Presentation · Gastroenterology
Predictors of Patients Receiving No Medication for Treatment of Eosinophilic Esophagitis in the United States: Data from the TARGET-EGIDS Cohort.
Read more →2024 · Poster Presentation · Poster Presentation · Gastroenterology
Time to Diagnosis Among Patients with Eosinophilic Esophagitis in the United States.
Read more →2024 · Poster Presentation · Poster Presentation · Methods/Pharmacoepi
Assessing The Value Of Linking Abstracted Medical Record Data With Administrative Claims Data To Study Patients With High-Risk Non-Muscle Invasive Bladder Cancer In The United States.
Read more →2024 · Abstract / Manuscript · Abstract / Manuscript
Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort.
Read more →2024 · Abstract / Manuscript · Abstract / Manuscript
High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort.
Read more →2024 · Poster Presentation · Poster Presentation · Hepatology
Relationship between liver biopsy fibrosis stage and clinical outcomes among persons with MASLD/MASH.
Read more →2024 · Oral Presentation · Oral Presentation · Hepatology
Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality.
Read more →2024 · Abstract / Manuscript · Abstract / Manuscript
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry.
Read more →2024 · Oral Presentation · Oral Presentation · Dermatology
Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA.
Read more →2024 · Abstract / Manuscript · Abstract / Manuscript
Factors Predicting Loss of Remission in Crohn’s Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD.
Read more →2024 · Abstract / Manuscript · Abstract / Manuscript
Use of tenofovir-based PrEP among pregnant women in South Africa.
Read more →2024 · Abstract / Manuscript · Abstract / Manuscript
Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study.
Read more →2024 · Poster Presentation · Approval / Commercialization · Dermatology
Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from the TARGET-DERM AD registry.
Read more →2023 · Poster Presentation · Poster Presentation · Hepatology
NASH Progression Rates Based on Fibrosis and Inflammation (NAS): A Paired Biopsy Analysis From a Natural History Cohort in the US.
Read more →2023 · Poster Presentation · Poster Presentation · Hepatology
A Prospective, Pragmatic Post-Authorisation Safety Study of Early Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients after Direct-Acting Antiviral (DAA) Therapy: DAA-PASS.
Read more →2023 · Poster Presentation · Approval / Commercialization · Dermatology
Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from TARGET-DERM registry.
Read more →2023 · Poster Presentation · Care · Dermatology
Impact of Therapeutic Inertia on Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Study from the TARGET-DERM AD Registry.
Read more →2023 · Poster Presentation · Poster Presentation · Dermatology
The role of itch resolution and skin clearance in patient-reported atopic dermatitis severity and quality of life: Real-world Insights from TARGET-DERM AD.
Read more →2023 · Oral Presentation · Care · Dermatology
Use of advanced systemic therapy in adolescent patients with moderate to severe atopic dermatitis in the TARGET DERM Registry.
Read more →2023 · Poster Presentation · Poster Presentation · Gastroenterology
Outcomes of early vs. delayed advanced therapy among patients with moderate ulcerative colitis in the United States: TARGET-IBD.
Read more →2023 · Poster Presentation · Poster Presentation · Gastroenterology
Treatment Journey among patients with moderate ulcerative colitis in the United States: TARGET-IBD.
Read more →2023 · Oral Presentation · Care · Methods/Pharmacoepi
Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-fracture Treatment Among Commercially Insured Postmenopausal Women in the United States.
Read more →2023 · Poster Presentation · Poster Presentation · Methods/Pharmacoepi
Analysis of discrimination and calibration of two cardiovascular risk scores in patients with non-alcoholic steatohepatitis shows a need for improved accuracy of these models.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
Impact of itch on quality of life in people with primary biliary cholangitis: a plain language summary.
Read more →2023 · Oral Presentation · Oral Presentation · Hepatology
Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non–Muscle-Invasive Bladder Cancer.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
When Emulating a Trial, Do as the Trialists Do: Missteps in Estimating Relative Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster Dose.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women.
Read more →2023 · Abstract / Manuscript · Abstract / Manuscript
High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.
Read more →2023 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi
HIV risk perception and PrEP adherence among South African women planning for pregnancy and participating in STI screening.
Read more →2023 · Oral Presentation · Care · Dermatology
Unmet Needs of Adolescents with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry.
Read more →2022 · Poster Presentation · Poster Presentation · Hepatology
The Role of Disease Severity and Gender in Polypharmacy Among Patients with NAFLD Enrolled in TARGET-NASH.
Read more →2022 · Poster Presentation · Poster Presentation · Hepatology
Longitudinal ALT Trajectories are Generally Stable Among Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): An Investigation Using Artificial Recurrent Neural Networks.
Read more →2022 · Poster Presentation · Care · Dermatology
Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: A Cross Sectional Study from the TARGET-DERM AD Cohort.
Read more →2022 · Poster Presentation · Care · Dermatology
Use of Advanced Systemic Therapy in Patients with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry.
Read more →2022 · Poster Presentation · Poster Presentation · Gastroenterology
The Impact of Early vs. Late Biologic Initiation Among Real World Patients with Crohn’s Disease in TARGET IBD.
Read more →2022 · Poster Presentation · Poster Presentation · Gastroenterology
Treatment patterns among moderate-to-severe ulcerative colitis patients in TARGET-IBD.
Read more →2022 · Poster Presentation · Poster Presentation · Gastroenterology
Inflammation on Index Biopsy Predicts Loss of Remission Among Ulcerative Colitis Patients with Endoscopic Remission: a US Cohort Analysis.
Read more →2022 · Poster Presentation · Poster Presentation · Methods/Pharmacoepi
Healthcare Utilization and Charges Associated with US Hospitalized Adult Patients with COVID 19.
Read more →2022 · Poster Presentation · Poster Presentation · Methods/Pharmacoepi
Association Between Clinical Outcomes and Patient Characteristics Among Hospitalized Adult Patients with COVID-19.
Read more →2022 · Abstract / Manuscript · Abstract / Manuscript
Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease.
Read more →2022 · Abstract / Manuscript · Abstract / Manuscript
Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.
Read more →2022 · Abstract / Manuscript · Abstract / Manuscript
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort.
Read more →2022 · Abstract / Manuscript · Abstract / Manuscript
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET‑IBD.
Read more →2022 · Abstract / Manuscript · Abstract / Manuscript
Postpartum Medicaid enrollment and churn in North Carolina.
Read more →2022 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi
HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017.
Read more →2022 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi
Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project.
Read more →2022 · Poster Presentation · Poster Presentation · Dermatology
Healthcare Disparities in Atopic Dermatitis: Insights from TARGET DERM Registry.
Read more →2021 · Poster Presentation · Poster Presentation · Hepatology
Determination of Optimal Thresholds for Significant Fibrosis in NAFLD Using Non-Invasive Tests from TARGET-NASH Study.
Read more →2021 · Poster Presentation · Poster Presentation · Gastroenterology
Histological Inflammation Predicts Loss of Remission Among Crohn’s Patients with Endoscopic Remission: A US Cohort Analysis.
Read more →2021 · Poster Presentation · Poster Presentation · Gastroenterology
Immunomodulators are Commonly Used as Concomitant Therapy with Vedolizumab or Ustekinumab: TARGET-IBD Real World Cohort.
Read more →2021 · Poster Presentation · Poster Presentation · Gastroenterology
Biologic-naïve Patients with Crohn’s Disease are More Likely to Achieve Mucosal Healing than Biologic-experienced Patients: TARGET-IBD Real World Cohort.
Read more →2021 · Abstract / Manuscript · Abstract / Manuscript
Liver Biopsy in the Real World—Reporting, Expert Concordance and Correlation with a Pragmatic Clinical Diagnosis.
Read more →2021 · Abstract / Manuscript · Abstract / Manuscript
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study.
Read more →2021 · Abstract / Manuscript · Abstract / Manuscript
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study.
Read more →2021 · Abstract / Manuscript · Abstract / Manuscript
Weight Loss and Weight Regain in Usual Clinical Practice: Results from the TARGET-NASH Observational Cohort.
Read more →2021 · Abstract / Manuscript · Abstract / Manuscript
Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV.
Read more →2021 · Abstract / Manuscript · Abstract / Manuscript
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease.
Read more →2021 · Abstract / Manuscript · Abstract / Manuscript
Methodology and initial results from a real-world observational cohort of patients with inflammatory bowel disease: TARGET-IBD.
Read more →2021 · Abstract / Manuscript · Abstract / Manuscript
Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice.
Read more →2021 · Abstract / Manuscript · Abstract / Manuscript
Medicaid Coverage Disruptions Among Children Enrolled in North Carolina Medicaid From 2016 to 2018.
Read more →2021 · Abstract / Manuscript · Abstract / Manuscript
Factors Associated with Readmission in the US Following Hospitalization with COVID-19.
Read more →2021 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi
Lipids testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019.
Read more →2021 · Poster Presentation · Care · Dermatology
Epidemiology and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: a Cross Sectional Study from the TARGET-DERM AD Cohort.
Read more →2021 · Poster Presentation · Care · Dermatology
Burden of Disease is Positively Associated with Disease Severity in Atopic Dermatitis.
Read more →2020 · Poster Presentation · Poster Presentation · Hepatology
A Pragmatic Clinical Prognostic Classification Suitable for Universal Application Stratifies Patients with NAFLD by Risk of Mortality and Both Hepatic and Extrahepatic Outcomes.
Read more →2020 · Poster Presentation · Poster Presentation · Hepatology
Heterogeneous Documentation and Poor Concordance of NASH Pathology May Limit its Clinical Utility in Real-World Practice.
Read more →2020 · Poster Presentation · Poster Presentation · Hepatology
Fibrosis Assessed by Non-Invasive Tests is Similar to Liver Biopsy for Predicting Clinical Outcomes: A TARGET-NASH Study.
Read more →2020 · Poster Presentation · Poster Presentation · Hepatology
Predicting advanced fibrosis using non-invasive clinical tests and modern machine learning methods in TARGET-NASH.
Read more →2020 · Poster Presentation · Care · Hepatology
Pruritus in Primary Biliary Cholangitis is Under-Treated in Clinical Practice: Results from TARGET-PBC.
Read more →2020 · Poster Presentation · Poster Presentation · Gastroenterology
Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD.
Read more →2020 · Abstract / Manuscript · Abstract / Manuscript
Opioid Use is More Common in Non-Alcoholic Fatty Liver Disease Patients with Cirrhosis, Higher Body Mass Index and Psychiatric Disease.
Read more →2020 · Abstract / Manuscript · Abstract / Manuscript
Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Co-morbid Diseases.
Read more →2020 · Abstract / Manuscript · Abstract / Manuscript
A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC.
Read more →2020 · Oral Presentation · Oral Presentation · Hepatology
Clinical Profile of Nonalcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus.
Read more →2020 · Abstract / Manuscript · Abstract / Manuscript
Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States.
Read more →2020 · Abstract / Manuscript · Abstract / Manuscript
Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines.
Read more →2020 · Abstract / Manuscript · Abstract / Manuscript
Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States.
Read more →2020 · Oral Presentation · Oral Presentation · Gastroenterology
Objective Disease Activity Assessment and Therapeutic Drug Monitoring is Lacking Prior to Biologic Therapy Changes in Routine Inflammatory Bowel Disease Clinical Practice: TARGET-IBD.
Read more →2020 · Poster Presentation · Poster Presentation · Dermatology
International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale.
Read more →2020 · Poster Presentation · Care · Gastroenterology
Oral Mesalamine Use in Crohn’s Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study.
Read more →2020 · Oral Presentation · Approval / Commercialization · Hepatology
Weight Loss and Change in Alanine Aminotransferase (ALT) Among Patients with Nonalcoholic Fatty Liver Disease (NAFLD) Receiving Standard Care in Real World Clinical Practice: TARGET-NASH.
Read more →2019 · Poster Presentation · Poster Presentation · Hepatology
Routinely Available Noninvasive Tests Perform Well in Identifying Patients with Advanced Fibrosis Due to NASH: Data from the TARGET-NASH Observational Cohort.
Read more →2019 · Poster Presentation · Poster Presentation · Hepatology
Patient Reported Outcomes Among Pediatric Patients with Nonalcoholic Fatty Liver Disease: TARGET-NASH.
Read more →2019 · Poster Presentation · Poster Presentation · Hepatology
Patterns of Medication Use Among Adult Patients with Elevated Serum ALT Levels in Patients with NAFLD: TARGET-NASH.
Read more →2019 · Poster Presentation · Poster Presentation · Hepatology
The Prescribing Patterns and Use of Statins in Patients with Nonalcoholic Fatty Liver Disease.
Read more →2019 · Poster Presentation · Poster Presentation · Hepatology
Opioid use in patients with NAFLD: prevalence and association with comorbidities and disease severity.
Read more →2019 · Poster Presentation · Poster Presentation · Hepatology
Lean NAFLD patients have lower prevalence of cardiovascular, metabolic and severe liver disease compared to overweight or obese patients with NAFLD.
Read more →2019 · Poster Presentation · Care · Hepatology
Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) overlap syndrome: Characteristics and response to obeticholic acid (OCA) in TARGET-PBC, a diverse, large United States (US) real- world cohort.
Read more →2019 · Poster Presentation · Approval / Commercialization · Hepatology
Change in Lipids: Characteristics and Response to Obeticholic Acid (OCA) in TARGET-PBC, a Diverse, Large United States (US) Real-world Cohort.
Read more →2019 · Poster Presentation · Poster Presentation · Hepatology
Management of Hepatocellular Carcinoma (HCC) in a Real Life Multinational, Longitudinal, Observational Study (TARGET-HCC).
Read more →2019 · Poster Presentation · Poster Presentation · Hepatology
Regional, racial/ethnic, and socioeconomic disparities and treatment outcomes in patients with hepatocellular carcinoma (HCC) in the US.
Read more →2019 · Poster Presentation · Care · Hepatology
Effectiveness of Tenofovir Alafenamide in Patients with Chronic Hepatitis B Treated in Usual Clinical Practice: Results from the TARGET-HBV Observational Cohort Study.
Read more →2019 · Poster Presentation · Care · Gastroenterology
Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study.
Read more →2019 · Poster Presentation · Care · Methods/Pharmacoepi
Factors Associated with Readmission Following COVID-19 Hospitalization.
Read more →2019 · Oral Presentation · Oral Presentation · Hepatology
Incidence of Achieving Weight Loss Goals in Usual Clinical Practice: Results for the TARGET-NASH Observational Cohort.
Read more →2019 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi
Lipid testing trends in the US before and after the release of the 2013 ACC/AHA cholesterol guidelines.
Read more →2018 · Poster Presentation · Poster Presentation · Hepatology
Characterization of polypharmacy in patients with NAFLD.
Read more →2018 · Poster Presentation · Poster Presentation · Hepatology
Clinical Profile of Adults with Nonalcoholic Steatohepatitis (NASH) with and without Type 2 Diabetes Mellitus (T2DM).
Read more →2018 · Poster Presentation · Poster Presentation · Hepatology
Nonalcoholic Fatty Liver Disease in Children in the U.S.: Clinical Characteristics of Participants Enrolled in TARGET-NASH.
Read more →2018 · Poster Presentation · Approval / Commercialization · Hepatology
Real World Evidence Showing High Rates of Cardiovascular Events in NAFLD Patients Regardless of Liver Disease.
Read more →2018 · Poster Presentation · Poster Presentation · Hepatology
Patient-Reported Indicators of Health and Symptoms in US Patients with Primary Biliary Cholangitis (PBC).
Read more →2018 · Poster Presentation · Approval / Commercialization · Hepatology
Primary Biliary Cholangitis (PBC) in the U.S.: Real World Effectiveness of Obeticholic Acid in TARGET-PBC.
Read more →2018 · Poster Presentation · Care · Hepatology
Primary Biliary Cholangitis (PBC) in the U.S.: Clinical Characteristics of Patients Enrolled in TARGET-PBC.
Read more →2018 · Poster Presentation · Poster Presentation · Gastroenterology
Development of a Novel Longitudinal Observational Cohort of Adult and Pediatric Patients with Inflammatory Bowel Disease: TARGET-IBD.
Read more →2018 · Abstract / Manuscript · Abstract / Manuscript
A Real-World Observational Cohort of Patients with Primary Biliary Cholangitis: TARGET-PBC Study Design and Rationale.
Read more →2018 · Abstract / Manuscript · Abstract / Manuscript
Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States.
Read more →2018 · Abstract / Manuscript · Abstract / Manuscript
Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US.
Read more →2018 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi
Real-world patterns of romiplostim treatment in adults with primary immune thrombocytopenia in the United States.
Read more →2017 · Poster Presentation · Poster Presentation · Hepatology
Sustained Elevation in Alkaline Phosphatase is Associated with Greater Disease Severity in Real World NAFLD in TARGET-NASH.
Read more →2017 · Poster Presentation · Care · Hepatology
Nonalcoholic Fatty Liver Disease in the U.S.: Clinical Characteristics of Patients Enrolled in TARGET-NASH.
Read more →2017 · Abstract / Manuscript · Abstract / Manuscript
Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: the TARGET-NASH study.
Read more →2017 · Oral Presentation · Oral Presentation · Methods/Pharmacoepi